Shenzhen Bioeasy Biotechnology Co., Ltd. (SHE:300942)

SHE:300942 Revenue

Shenzhen Bioeasy Biotechnology had revenue of 74.73M CNY in the quarter ending September 30, 2026, a decrease of -2.11%. This brings the company's total for the last twelve months to 280.69M, up 11.46% year-over-year. In the year 2025, Shenzhen Bioeasy Biotechnology had annual revenue of 263.23M with 17.38% growth. That makes Shenzhen Bioeasy Biotechnology the 29,173rd largest company in the world by revenue and 4,901st in China.

• Revenue (ttm): 280.69M
• Revenue Growth: +11.46%
• P/S Ratio: 8.57
• Revenue / Employee: 517.89K
• Employees: 542
• Market Cap: 2.37B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Food Rapid Testing Business 237.43M 90.2%
• Animal Disease Detection 14.46M 5.5%
• Park Operation Services 11.34M 4.3%

By Geography

Chart

• China 153.35M 58.3%
• Foreign 109.87M 41.7%

Fiscal year ended Dec 31, 2025 See the full SHE:300942 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	263.23M	38.98M	17.38%
Dec 31, 2024	224.25M	-29.86M	-11.75%
Dec 31, 2023	254.11M	-432.79M	-63.01%
Jan 1, 2023	686.90M	89.36M	14.95%
Jan 1, 2022	597.54M	339.08M	131.20%

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 3, 2026

Data Sources Report a data error